XINYUAN REAL ESTATE CO., LTD. Financials Xinyuan Real Estate Co., Ltd.
Equities
XIN
US98417P2048
Real Estate Development & Operations
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.72 USD | 0.00% |
|
+4.62% | 0.00% |
| Feb. 07 | Xinyuan Real Estate Co., Ltd. Appoints Fei Xie, as A New Director | CI |
| Jan. 16 | ADRs End Lower; Aslan Pharmaceuticals Declines 38% | DJ |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,879 | 244.8 | 1,661 | 941.7 | 262.5 | 150.4 |
| Enterprise Value (EV) 2 | 5,411 | 3,095 | 4,268 | 3,033 | 2,098 | 2,003 |
| P/E ratio | 46.2 x | 22.9 x | 21.9 x | -9.53 x | -0.51 x | -0.57 x |
| Yield | 0.9% | 1.53% | 1.52% | - | - | - |
| Capitalization / Revenue | 1.46 x | 0.11 x | 0.67 x | 0.54 x | 0.17 x | 0.16 x |
| EV / Revenue | 2.74 x | 1.4 x | 1.72 x | 1.74 x | 1.37 x | 2.11 x |
| EV / EBITDA | 20.8 x | 7.92 x | 13 x | 34.1 x | -12.5 x | -49.5 x |
| EV / FCF | -57.5 x | -590 x | 5.55 x | 6.44 x | 7.78 x | -3.46 x |
| FCF Yield | -1.74% | -0.17% | 18% | 15.5% | 12.9% | -28.9% |
| Price to Book | 2.89 x | 2.3 x | 2.06 x | 1.15 x | 0.85 x | -2.14 x |
| Nbr of stocks (in thousands) | 6,498 | 6,442 | 6,311 | 6,560 | 6,560 | 5,438 |
| Reference price 3 | 443.1 | 261.3 | 263.2 | 143.6 | 40.02 | 27.66 |
| Announcement Date | 4/30/18 | 4/29/19 | 4/29/20 | 3/8/22 | 7/29/22 | 5/30/23 |
1CNY in Million2USD in Million3CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,977 | 2,218 | 2,483 | 1,746 | 1,536 | 950 |
| EBITDA 1 | 260.8 | 390.6 | 327.4 | 88.91 | -167.8 | -40.44 |
| EBIT 1 | 247.1 | 375.4 | 309.9 | 71.4 | -186 | -53.61 |
| Operating Margin | 12.5% | 16.93% | 12.48% | 4.09% | -12.11% | -5.64% |
| Earnings before Tax (EBT) 1 | 193.2 | 250.4 | 233.5 | 67.58 | -420.5 | -249.4 |
| Net income 1 | 63.63 | 73.03 | 68.34 | -81.04 | -417.3 | -263.4 |
| Net margin | 3.22% | 3.29% | 2.75% | -4.64% | -27.17% | -27.72% |
| EPS 2 | 9.600 | 11.40 | 12.00 | -15.07 | -77.80 | -48.84 |
| Free Cash Flow 1 | -94.09 | -5.245 | 769.4 | 470.8 | 269.8 | -579.4 |
| FCF margin | -4.76% | -0.24% | 30.99% | 26.97% | 17.57% | -60.99% |
| FCF Conversion (EBITDA) | - | - | 234.97% | 529.59% | - | - |
| FCF Conversion (Net income) | - | - | 1,125.75% | - | - | - |
| Dividend per Share 2 | 4.000 | 4.000 | 4.000 | - | - | - |
| Announcement Date | 4/30/18 | 4/29/19 | 4/29/20 | 3/8/22 | 7/29/22 | 5/30/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 2,532 | 2,850 | 2,607 | 2,091 | 1,835 | 1,852 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 9.71 x | 7.298 x | 7.961 x | 23.52 x | -10.94 x | -45.8 x |
| Free Cash Flow 1 | -94.1 | -5.24 | 769 | 471 | 270 | -579 |
| ROE (net income / shareholders' equity) | 8.12% | 11.8% | 10.8% | -7.42% | -57.4% | -104% |
| ROA (Net income/ Total Assets) | 2.91% | 3.25% | 2.51% | 0.59% | -1.65% | -0.54% |
| Assets 1 | 2,185 | 2,244 | 2,727 | -13,703 | 25,331 | 48,331 |
| Book Value Per Share 2 | 153.0 | 114.0 | 128.0 | 124.0 | 47.20 | -12.90 |
| Cash Flow per Share 2 | 138.0 | 113.0 | 123.0 | 173.0 | 79.10 | 52.40 |
| Capex 1 | 5.57 | 9.13 | 5.51 | 1.29 | 2.06 | 0.03 |
| Capex / Sales | 0.28% | 0.41% | 0.22% | 0.07% | 0.13% | 0% |
| Announcement Date | 4/30/18 | 4/29/19 | 4/29/20 | 3/8/22 | 7/29/22 | 5/30/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 16.34M | |
| +9.02% | 10.79B | |
| -34.32% | 10.32B | |
| -28.99% | 7.2B | |
| -5.56% | 7.01B | |
| -0.34% | 6.53B | |
| -3.03% | 6.09B | |
| -5.92% | 3.54B | |
| +12.96% | 3.57B | |
| +27.36% | 3.32B |
- Stock Market
- Equities
- XIN Stock
- Financials Xinyuan Real Estate Co., Ltd.
